BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 3892353)

  • 21. Evidence that norepinephrine and epinephrine systems mediate the stimulatory effects of ovarian hormones on luteinizing hormone and luteinizing hormone-releasing hormone.
    Adler BA; Johnson MD; Lynch CO; Crowley WR
    Endocrinology; 1983 Oct; 113(4):1431-8. PubMed ID: 6352246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Opioid-glutamate-nitric oxide connection in the regulation of luteinizing hormone secretion in the rat.
    Bhat GK; Mahesh VB; Ping L; Chorich L; Wiedmeier VT; Brann DW
    Endocrinology; 1998 Mar; 139(3):955-60. PubMed ID: 9492025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of hypothalamic gonadotropin-releasing hormone and neuropeptide Y concentrations by progesterone and corticosteroids in immature rats: correlation with luteinizing hormone and follicle-stimulating hormone release.
    Brann DW; McDonald JK; Putnam CD; Mahesh VB
    Neuroendocrinology; 1991 Nov; 54(5):425-32. PubMed ID: 1749457
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin-1 inhibits the ovarian steroid-induced luteinizing hormone surge and release of hypothalamic luteinizing hormone-releasing hormone in rats.
    Kalra PS; Sahu A; Kalra SP
    Endocrinology; 1990 Apr; 126(4):2145-52. PubMed ID: 2180683
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of the GABA-A receptor agonist and antagonist on the in vitro release of hypothalamic catecholamines: apparent parallelism between these effects and the LHRH secretion in adult male rats.
    Feleder C; Wuttke W; Moguilevsky JA
    Exp Clin Endocrinol Diabetes; 1999; 107(1):80-4. PubMed ID: 10077361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peripubertal development of noradrenergic stimulation of luteinizing hormone-releasing hormone neurosecretion in vitro.
    Clough RW; Hoffman GE; Sladek CD
    Brain Res; 1988 Apr; 446(1):121-32. PubMed ID: 3285962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Opiate-induced hypersensitivity to testosterone feedback: pituitary involvement.
    Kalra PS; Sahu A; Kalra SP
    Endocrinology; 1988 Mar; 122(3):997-1003. PubMed ID: 3277841
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LHRH-I release from quail hypothalamic slices measured by specific EIA.
    Li Q; Paciotti GF; Tamarkin L; Ottinger MA
    Gen Comp Endocrinol; 1994 Jul; 95(1):13-24. PubMed ID: 7926649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progesterone suppression of glutamic acid decarboxylase (GAD67) mRNA levels in the preoptic area: correlation to the luteinizing hormone surge.
    Unda R; Brann DW; Mahesh VB
    Neuroendocrinology; 1995 Dec; 62(6):562-70. PubMed ID: 8751281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreases in mediobasal hypothalamic and preoptic area opioid ([3H]naloxone) binding are associated with the progesterone-induced luteinizing hormone surge.
    Jacobson W; Kalra SP
    Endocrinology; 1989 Jan; 124(1):199-206. PubMed ID: 2535804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endogenous opioid peptides mediate the interleukin-1-induced inhibition of the release of luteinizing hormone (LH)-releasing hormone and LH.
    Kalra PS; Fuentes M; Sahu A; Kalra SP
    Endocrinology; 1990 Nov; 127(5):2381-6. PubMed ID: 2226323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of intraventricular administration of catecholamines on luteinizing hormone release in morphine-treated rats.
    Kalra SP; Gallo RV
    Endocrinology; 1983 Jul; 113(1):23-8. PubMed ID: 6345142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of galanin in stimulation of pituitary luteinizing hormone secretion as revealed by a specific receptor antagonist, galantide.
    Sahu A; Xu B; Kalra SP
    Endocrinology; 1994 Feb; 134(2):529-36. PubMed ID: 7507825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of ovarian steroids on in vitro release of LHRH from mediobasal hypothalamus.
    Drouva SV; Laplante E; Kordon C
    Neuroendocrinology; 1983 Nov; 37(5):336-41. PubMed ID: 6358934
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo biosynthesis of hypothalamic luteinizing hormone releasing hormone in individual free-running female rats.
    Krause JE; Advis JP; McKelvy JF
    Endocrinology; 1982 Jul; 111(1):344-6. PubMed ID: 7044767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro LHRH release from superfused hypothalamus as a function of the rat estrous cycle: effect of progesterone.
    Kim K; Ramirez VD
    Neuroendocrinology; 1986; 42(5):392-8. PubMed ID: 3517668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In-vitro pulsatile luteinizing hormone-releasing hormone output is dependent on hypothalamic region and the stage of the estrous cycle.
    Meyer DC
    Biol Reprod; 1987 Dec; 37(5):1207-14. PubMed ID: 3327540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of prenatal morphine and adult estrogen administration on mu-opioid inhibition of norepinephrine release from hypothalamic slices.
    Vathy I; Etgen AM
    Neuroendocrinology; 1996 Jan; 63(1):61-8. PubMed ID: 8839356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alterations in luteinizing hormone-releasing hormone release from the mediobasal hypothalamus of ovariectomized, steroid-primed middle-aged rats as measured by push-pull perfusion.
    Rubin BS; Bridges RS
    Neuroendocrinology; 1989 Mar; 49(3):225-32. PubMed ID: 2654689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence that nitric oxide may mediate the ovarian steroid-induced luteinizing hormone surge: involvement of excitatory amino acids.
    Bonavera JJ; Sahu A; Kalra PS; Kalra SP
    Endocrinology; 1993 Dec; 133(6):2481-7. PubMed ID: 8243268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.